Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

Saved in:
Bibliographic Details
Title: Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.
Authors: Campbell KM; University of California, Los Angeles Los Angeles, CA United States., Chen DG; University of California, Los Angeles Los Angeles, CA United States., Bustami ZE; Columbia University New York, NY United States., Naser Al Deen N; University of California, Los Angeles Los Angeles, CA United States., Medina E; University of California, Los Angeles Los Angeles, CA United States., Gonzalez CR; University of California, Los Angeles Los Angeles, CA United States., Maxey J; Parker Institute for Cancer Immunotherapy San Francisco, CA United States., Thompson MA; Parker Institute for Cancer Immunotherapy San Francisco, CA United States., Samorodnitsky S; Fred Hutchinson Cancer Center Seattle, WA United States., Kuklinski LF; University of California, Los Angeles Los Angeles, CA United States., Perez Garcilazo I; University of California, Los Angeles Los Angeles, CA United States., Baselga-Carretero I; University of California, Los Angeles Los Angeles, CA United States., Vega-Crespo A; University of California, Los Angeles Los Angeles, CA United States., Chen JM; University of California, Los Angeles United States., Elumalai R; Agilent Technologies (United States) Santa Clara, CA United States., Visitacion M; Agilent Technologies (United States) Santa Clara, CA United States., Schiemann R; Parker Institute for Cancer Immunotherapy San Francisco, CA United States., Padron L; Parker Institute for Cancer Immunotherapy San Francisco, CA United States., Chang C; University of California, Los Angeles Los Angeles, CA United States., Zelin AE; University of California, Los Angeles Los Angeles, CA United States., Chelluri SS; University of California, Los Angeles Los Angeles, CA United States., Boffo S; Bristol-Myers Squibb (United States) Lawrenceville, NJ United States., Kendra KL; The Ohio State University Columbus, Ohio United States., Chmielowski B; University of California, Los Angeles Los Angeles, CA United States., Truong TG; Kaiser Permanente Vallejo Medical Center Vallejo, CA United States., Khushalani NI; Moffitt Cancer Center Tampa, FL United States., Collichio F; UNC Lineberger Comprehensive Cancer Center Chapel Hill, NC United States., Ikeguchi AP; The University of Texas MD Anderson Cancer Center Houston, TX United States., Victor AI; University of Rochester Rochester, NY United States., Margolin KA; Saint John's Cancer Institute, Providence Saint John's Health Center Santa Monica, United States (+1) United States., Johnson DB; Vanderbilt University Medical Center Nashville, TN United States., Chen Y; Michigan Cancer Research Consortium Grand Rapids, MI United States., Sosman JA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, IL United States., Patel SP; University of Colorado Anschutz Medical Campus Aurora United States., Hu-Lieskovan S; University of Utah Health Care Salt Lake City, Utah United States., Moon J; Fred Hutchinson Cancer Center United States., Wells DK; Parker Institute for Cancer Immunotherapy San Francisco, CA United States., Spencer CN; Rare Cancer Research Foundation Housotn, TX United States., Bellasea S; Fred Hutchinson Cancer Center Seattle, WA United States., Vanderwalde AM; Caris Life Sciences (United States) Los Angeles, CA United States., Wu MC; Fred Hutchinson Cancer Center Seattle, WA United States., Scumpia PO; University of California, Los Angeles Los Angeles, Ca United States., Ribas A; University of California, Los Angeles Los Angeles, CA United States.
Source: Cancer discovery [Cancer Discov] 2026 Apr 21. Date of Electronic Publication: 2026 Apr 21.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-25-1745